Allison Berke is a senior engineer at RAND in the Center for AI, Security, and Technology. She works on biosecurity and AI security research and policy. Her research focuses on safely and securely developing biotechnologies for defense and health applications. She teaches science and technology policy at Stanford University, and has previously taught at Duke University and the Middlebury Institute of International Studies. She advises national laboratories and AI companies on the secure development of biosciences, and has experience in cybersecurity policy, business technology, and secure computing. Berke has a Ph.D. in bioengineering from the University of California, Berkeley.

Education

Ph.D. in bioengineering, University of California-Berkeley; B.S. in mathematics, Massachusetts Institute of Technology; B.S. in biology, Massachusetts Institute of Technology

Selected Work

  • Josh Dettman, Emily Lathrop, Aurelia Attal-Juncqua, Matthew L. Nicotra, Allison Berke, "Prioritizing Feasible and Impactful Actions to Enable Secure AI Development and Use in Biology," Biotechnology and Bioengineering, 2026
  • Berke, Allison, Kyle A. Kilian, Graham Griffin, Jay Atanda, and Enrique Vazquez, Verifiable Audit Trails for AI-Enabled Biological Design Tools: A Proposal for Verifiable Biodesign Logging, RAND Corporation (PE-A4613-1), 2026
  • Berke, Allison, Forrest W. Crawford, Toby Webster, James Smith, Sana Zakaria, and Sella Nevo, Data and AI-Enabled Biological Design: Risks Related to Biological Training Data and Opportunities for Governance, RAND Corporation (PE-A3886-1), 2025
  • Pannu, Jaspreet, Sarah L. Gebauer, Henry Alexander Bradley, Dulani Woods, Doni Bloomfield, Allison Berke, Greg McKelvey, Jr., Anita Cicero, and Tom Inglesby, Defining Hazardous Capabilities of Biological AI Models: Expert Convening to Inform Future Risk Assessment, RAND Corporation (CF-A3649-1), 2025
  • Lee, Jeffrey, Bria Persaud, Barbara Del Castello, Allison Berke, and Gustavs Zilgalvis, Documenting Cloud Labs and Examining How Remotely Operated Automated Laboratories Could Enable Bad Actors, RAND Corporation (PE-A3851-1), 2025
  • Williams, Adeline E., Saskia Popescu, Allison Berke, Enrique Vazquez, and Sella Nevo, Identifying and Closing Gaps in the Federal Select Agent Program: Opportunities for Improvement in an Era of Emerging Biotechnologies, RAND Corporation (RR-A3628-1), 2025
  • Dettman, Josh, Emily Lathrop, Aurelia Attal-Juncqua, Matthew L. Nicotra, and Allison Berke, Prioritizing Feasible and Impactful Actions to Enable Secure Artificial Intelligence Development and Use in Biology, RAND Corporation (WR-A4213-1), 2025
  • Manheim, David, Adeline E. Williams, Casey Aveggio, and Allison Berke, Understanding the Theoretical Limits of AI-Enabled Pathogen Design: Insights from a Delphi Study, RAND Corporation (RR-A4087-1), 2025

Authored by Allison Berke

  • Content Type
  • Topic
  • Region
  • Date
11 Results